Related Experiment Video
Updated: Mar 2, 2026

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
A randomized control trial of integrated care for families managing infant colic
Amy L Salisbury1, Pamela High2, Jean E Twomey1
1Women & Infants Hospital, Brown Center for the Study of Children at Risk and Warren Alpert Medical School, Brown University.
Insights
Family-centered treatment significantly reduced infant colic symptoms, including crying and feeding issues, compared to standard care. This integrated approach improved infant sleep and overall family well-being more rapidly.
Area of Science:
- Pediatrics
- Mental Health
- Family Medicine
Background:
- Infant colic is a common condition causing significant distress for families.
- Standard pediatric care for infant colic may not fully address underlying issues.
- Integrated care models offer a potential solution for complex infant behavioral problems.
Purpose of the Study:
- To evaluate the effectiveness of a family-centered integrated care model for infant colic.
- To compare the outcomes of family-centered treatment (TX) with standard pediatric care (SC).
Main Methods:
- A randomized clinical trial involving 62 families with colicky infants.
- Participants were assigned to either family-centered treatment or standard care.
- Data collected included infant behavior diaries, colic symptom checklists, and parental mental health assessments.
Main Results:
- Family-based treatment accelerated the reduction of infant crying compared to standard care.
- Infants in the family-centered group experienced more sleep and less feeding time post-treatment.
- Parental stress and depression levels were not explicitly detailed but implied improvements through symptom reduction.
Conclusions:
- Individualized, family-based integrated care is more effective in rapidly reducing infant colic symptoms.
- This model positively impacts infant sleep and feeding patterns.
- Integrated care approaches show promise for managing infant colic and supporting family well-being.
Abstract:
This article presents a randomized clinical trial examining the effectiveness of a unique model of integrated care for the treatment of infant colic. Families seeking help for infant colic were randomized to either the family-centered treatment (TX; n = 31) or standard pediatric care (SC; n = 31). All parents completed 3 days of Infant Behavior Diaries (Barr et al., 1998) and the Colic Symptom Checklist (Lester, 1997), Beck Depression Inventory (Beck & Steer, 1984), and Parenting Stress Index 3rd ed.-SF (Abidin, 1995). TX families were seen three times by a pediatrician and a mental health clinician within 1, 2, and 6 weeks of baseline data. TX families received individualized treatment plans addressing problem areas of sleep, feeding, routine, and family mental health. SC families were seen only by their own healthcare provider. All families were visited at home by a research assistant to retrieve data at 2, 6, and 10 weeks after baseline. Family-based treatment accelerated the rate of reduction of infant crying faster than did standard pediatric care. Infants in the TX group had more hours of sleep at 2 weeks posttreatment and spent less time feeding at 2, 6, and 10 weeks posttreatment than did SC infants. Results indicate that individualized family-based treatment reduces infant colic more rapidly than does standard pediatric care.
More Related Videos
11:50Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
Published on: January 7, 2020
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...